Seaport Therapeutics Inc. Common Stock

SPTX | NASDAQ

$19.62

+$0.02 (+0.10%)

Nov 2, 2026, 11:26 AM ET · Market open

Fiscal Quarter Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026
Net Income	-62.6M	-25.41M
Depreciation & Amortization	351K	357K
Stock-Based Compensation	n/a	2.57M
Other Working Capital	-1.31M	-247K
Other Non-Cash Items	36.5M	-223K
Deferred Income Tax	n/a	n/a
Change in Working Capital	-396K	2.53M
Operating Cash Flow	-26.14M	-20.17M
Capital Expenditures	n/a	n/a
Cash Acquisitions	n/a	n/a
Purchase of Investments	-253.5M	-47.15M
Sales Maturities Of Investments	50M	75M
Other Investing Acitivies	n/a	n/a
Investing Cash Flow	-203.5M	27.85M
Debt Repayment	n/a	n/a
Common Stock Repurchased	n/a	n/a
Dividend Paid	n/a	n/a
Other Financial Acitivies	240.12M	-783K
Financial Cash Flow	240.93M	-783K
Net Cash Flow	11.31M	6.87M
Free Cash Flow	-26.14M	-20.17M
Adj. Free Cash Flow	-26.14M	-22.74M
Maintenance CapEx	n/a	n/a
Growth CapEx	n/a	n/a
Owner Earnings	-26.14M	-20.17M